It’s official. CMS is going forward with its controversial 2018 PAMA Clinical Laboratory Fee Schedule (CLFS). Regrettably, the final version closely tracks the preliminary one (See GCA, Oct. 24, 2017, for the details) with just a few minor adjustments: 1. Phase-In Reduction Cap of Cuts Over 10% Situation: The National Limitation Amount (NLA) for a…
Medicare Reimbursement: CMS Finalizes Controversial PAMA Fee Schedule
by Glenn S. Demby | Dec 12, 2017 | CLIA-nir, CMS-nir, Fee Schedules-nir, National Lab Reporter, Reimbursement-nir